|
1
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: Defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hartgrink HH, Jansen EP, van Grieken NC
and van de Velde CJ: Gastric cancer. Lancet. 374:477–490. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mattick JS: Challenging the dogma: The
hidden layer of non-protein-coding RNAs in complex organisms.
Bioessays. 25:930–939. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mattick JS: RNA regulation: A new
genetics? Nat Rev Genet. 5:316–323. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Szymanski M, Barciszewska MZ, Erdmann VA
and Barciszewski J: A new frontier for molecular medicine:
Noncoding RNAs. Biochim Biophys Acta. 1756:65–75. 2005.PubMed/NCBI
|
|
7
|
Prasanth KV and Spector DL: Eukaryotic
regulatory RNAs: An answer to the ‘genome complexity’ conundrum.
Genes Deve. 21:11–42. 2007. View Article : Google Scholar
|
|
8
|
Huarte M and Rinn JL: Large non-coding
RNAs: Missing links in cancer? Hum Mol Genet. 19:R152–R161. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pauli A, Rinn JL and Schier AF: Non-coding
RNAs as regulators of embryogenesis. Nat Rev Genet. 12:136–149.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rinn JL, Kertesz M, Wang JK, Squazzo SL,
Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E and
Chang HY: Functional demarcation of active and silent chromatin
domains in human HOX loci by noncoding RNAs. Cell. 129:1311–1323.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Khalil AM, Guttman M, Huarte M, Garber M,
Raj A, Morales D Rivea, Thomas K, Presser A, Bernstein BE, van
Oudenaarden A, et al: Many human large intergenic noncoding RNAs
associate with chromatin-modifying complexes and affect gene
expression. Proc Natl Acad Sci USA. 106:pp. 11667–11672. 2009;
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Spitale RC, Tsai MC and Chang HY: RNA
templating the epigenome: Long noncoding RNAs as molecular
scaffolds. Epigenetics. 6:539–543. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Costa FF: Non-coding RNAs: Meet thy
masters. Bioessays. 32:599–608. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Popov N and Gil J: Epigenetic regulation
of the INK4b-ARF-INK4a locus: In sickness and in health.
Epigenetics. 5:685–690. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Calin GA, Liu CG, Ferracin M, Hyslop T,
Spizzo R, Sevignani C, Fabbri M, Cimmino A, Lee EJ, Wojcik SE, et
al: Ultraconserved regions encoding ncRNAs are altered in human
leukemias and carcinomas. Cancer Cell. 12:215–229. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sobin LH and Compton CC: TNM seventh
edition: What's new, what's changed: Communication from the
International Union Against Cancer and the American Joint Committee
on Cancer. Cancer. 116:5336–5339. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak and Schmittgen: Analysis of relative
gene expression data using real-time quantitative PCR and the
2−ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nault JC and Zucman-Rossi J: Genetics of
hepatobiliary carcinogenesis. Semin Liver Dis. 31:173–187. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kanwal R and Gupta S: Epigenetic
modifications in cancer. Clin Genet. 81:303–311. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Oliveira C, Seruca R, Seixas M and
Sobrinho-Simões M: The clinicopathological features of gastric
carcinomas with microsatellite instability may be mediated by
mutations of different ‘target genes’: A study of the TGF beta RII
IGFII R and BAX genes. Am J Pathol. 153:1211–1219. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dos Santos NR and Van Kessel AG:
Chromosomal abnormalities: Detection and implications for cancer
development. Anticancer Res. 19:4697–4714. 1999.PubMed/NCBI
|
|
22
|
Ochi H, Douglass HO Jr and Sandberg AA:
Cytogenetic studies in primary gastric cancer. Cancer Genet
Cytogenet. 22:295–307. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Seruca R, Castedo S, Correia C, Gomes P,
Carneiro F, Soares P, de Jong B and Sobrinho-Simões M: Cytogenetic
findings in eleven gastric carcinomas. Cancer Genet Cytogenet.
68:42–48. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Panani AD, Ferti A, Malliaros S and Raptis
S: Cytogenetic study of 11 gastric adenocarcinomas. Cancer Genet
Cytogenet. 81:169–172. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Seruca R, Constancia M, Dossantos N, David
L, Queimado L, Carvalho F and Carneiro F: Allele loss in human
gastric carcinomas-relation to tumor progression and
differentiation. Int J Oncol. 7:1159–1166. 1995.PubMed/NCBI
|
|
26
|
Gleeson CM, Sloan JM, McGuigan JA, Ritchie
AJ, Weber JL and Russell SE: Allelotype analysis of adenocarcinoma
of the gastric cardia. Br J Cancer. 76:1455–1465. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Queimado L, Seruca R, Costa-Pereira A and
Castedo S: Identification of two distinct regions of deletion at 6q
in gastric carcinoma. Genes Chromosomes Cancer. 14:28–34. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Prensner JR and Chinnaiyan AM: The
emergence of lncRNAs in cancer biology. Cancer Discov. 1:391–407.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Morris KV and Vogt PK: Long antisense
non-coding RNAs and their role in transcription and oncogenesis.
Cell Cycle. 9:2544–2547. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu Y, Chang R, Peng Z, Wang Y, Ji W, Guo
J, Song L, Dai C, Wei W, Wu Y, et al: Loss of polarity protein AF6
promotes pancreatic cancer metastasis by inducing Snail expression.
Nat Commun. 6:71842015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sun TT, Wang Y, Cheng H, Xiao HZ, Xiang
JJ, Zhang JT, Yu SB, Martin TA, Ye L, Tsang LL, et al: Disrupted
interaction between CFTR and AF-6/afadin aggravates malignant
phenotypes of colon cancer. Biochim Biophys Acta. 1843:618–628.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yamamoto T, Mori T, Sawada M, Matsushima
H, Ito F, Akiyama M and Kitawaki J: Loss of AF-6/afadin induces
cell invasion, suppresses the formation of glandular structures and
might be a predictive marker of resistance to chemotherapy in
endometrial cancer. BMC Cancer. 15:2752015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fournier G, Cabaud O, Josselin E, Chaix A,
Adélaïde J, Isnardon D, Restouin A, Castellano R, Dubreuil P,
Chaffanet M, et al: Loss of AF6/afadin, a marker of poor outcome in
breast cancer, induces cell migration, invasiveness and tumor
growth. Oncogene. 30:3862–3874. 2011. View Article : Google Scholar : PubMed/NCBI
|
